339 related articles for article (PubMed ID: 17489965)
21. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
Santori G; Andorno E; Morelli N; Antonucci A; Bottino G; Mondello R; Castiglione AG; Valente R; Ravazzoni F; Di Domenico S; Valente U
Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
[TBL] [Abstract][Full Text] [Related]
22. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
23. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
[TBL] [Abstract][Full Text] [Related]
24. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
Santoyo J; Suarez MA; Fernandez-Aguilar JL; Perez Daga JA; Sanchez-Perez B; Ramirez C; Aranda JM; Rodríguez-Canete A; Gonzalez-Sanchez A
Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
[TBL] [Abstract][Full Text] [Related]
25. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
[TBL] [Abstract][Full Text] [Related]
26. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
[TBL] [Abstract][Full Text] [Related]
27. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
28. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
29. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis.
Huo TI; Wang YW; Yang YY; Lin HC; Lee PC; Hou MC; Lee FY; Lee SD
Liver Int; 2007 May; 27(4):498-506. PubMed ID: 17403190
[TBL] [Abstract][Full Text] [Related]
30. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
[TBL] [Abstract][Full Text] [Related]
31. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
Teh SH; Sheppard BC; Schwartz J; Orloff SL
Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
[TBL] [Abstract][Full Text] [Related]
32. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
[TBL] [Abstract][Full Text] [Related]
33. Evidence-based incorporation of serum sodium concentration into MELD.
Biggins SW; Kim WR; Terrault NA; Saab S; Balan V; Schiano T; Benson J; Therneau T; Kremers W; Wiesner R; Kamath P; Klintmalm G
Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
Chan HL; Chim AM; Lau JT; Hui AY; Wong VW; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
[TBL] [Abstract][Full Text] [Related]
35. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
36. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
[TBL] [Abstract][Full Text] [Related]
37. Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation.
Raszeja-Wyszomirska J; Wasilewicz MP; Wunsch E; Szymanik B; Jarosz K; Wójcicki M; Milkiewicz P
Transplant Proc; 2009 Oct; 41(8):3114-6. PubMed ID: 19857689
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study.
Schepke M; Appenrodt B; Heller J; Zielinski J; Sauerbruch T
Liver Int; 2006 Sep; 26(7):834-9. PubMed ID: 16911466
[TBL] [Abstract][Full Text] [Related]
39. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis.
Hsu CY; Lin HC; Huang YH; Su CW; Lee FY; Huo TI; Lee PC; Lee JY; Lee SD
Dig Liver Dis; 2010 Feb; 42(2):137-42. PubMed ID: 19595648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
